Faron Pharmaceuticals Oy (FARN)
Market Closed
5 Feb, 12:00 AM
LSE LSE Primary 
XHEL £
162. 50
-2.5
-1.5152%
£
74.05M Market Cap
- P/E Ratio
- Div Yield
2,024 Volume
- Eps
£ 165
Previous Close Want to track FARN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Faron Pharmaceuticals Oy (FARN) Statistics
Valuation metrics
Market Cap 74.05M
Enterprise value 70.75M
Trailing P/E (ttm) -3.36
Forward P/E -
PEG ratio -1.88
Price/Sales (ttm) -
Price/Book (mrq) 5.64
Enterprise Value/Revenue -
Enterprise Value/EBITDA -3.69
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 54.1K
Average volume (90 days) 67.93K
Price summary
52-Week low 146
52-Week high 270
Beta -
50-Day moving average 37.28
200-Day moving average 41.63
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.46%
Return on equity 4.76%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.11
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.21
Total debt (mrq) -
Total Debt/Equity (mrq) 1.54
Current ratio (mrq) 2.4%
Book value per share (mrq) 0.08
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
